The challenges of expensive specialty medications and high out-of-pocket costs were the focus of a recent New York Times article, which featured two PAN Foundation grant recipients and quoted PAN’s Chief Advocacy and Engagement Officer Amy Niles.
In the article, authors Gina Kolata and Francesca Paris describe the barriers many patients across the country face as they seek care, particularly those who need specialty medications. The authors also highlight research that shows many with Medicare insurance will not be able to afford their prescriptions, even after the $2,000 Medicare Part D annual cap takes effect in 2025.
Though PAN’s charitable assistance helps many—one patient in the article said that PAN saved him—Niles shared that the need for financial help is so great “that we are just scratching the surface.”
Was this helpful?